President Donald Trump surprised most of America on Tuesday night when he spoke out against the $900 billion COVID stimulus bill recently approved by Congress, putting its full passage into question.
And yet, the stock market barely budged Wednesday morning. Dow Jones Industrial Average, S&P 500 and Nasdaq Composite futures were all in the black heading into the day's trading session.
Specifically, Trump didn't outright threaten to veto the plan, which includes $600 stimulus checks. But he did call it a "disgrace" and urged Congress to up the amount to $2,000 per American. He also rallied against "unnecessary items from this legislation," seeming to confuse the coronavirus rescue package and the omnibus spending bill that was passed alongside it.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Nonetheless, this threatens to at least delay much-needed relief to American individuals and small businesses, the latter of which was expected to benefit from access to another $285 million in the restarted Paycheck Protection Program (PPP).
So why does the stock market appear so sanguine?
"The possibility of a failed stimulus deal means almost nothing for the stock market because stocks still rose over the past few months when there was no stimulus and no likelihood of one coming," says David Bahnsen, chief investment officer of California-based The Bahnsen Group. "The market didn't move up much in recent days when a deal was finalized, before this latest speed bump in passing a stimulus deal."
He believes that the stock market still expects some sort of stimulus to happen, regardless of the form it takes.
"While I believe there are sufficient votes to override a veto from President Trump," he says, "I also believe President Trump could actually get what he wants in a revision of the stimulus deal."
Raymond James analysts agree that the president's demands for revisions to the COVID relief bill "raise the individual payment amount to $2,000 significantly raises uncertainty for the days ahead, but our base case remains that the bill passed by Congress will become law."
They don't, however, believe that a version with $2,000 checks is imminent.
"The package passed both the House and the Senate with veto-proof margins and the $2,000 payment level (the Democrats' original proposal in the HEROES Act) has no support among Republican lawmakers," they say.
It's also possible that so-called Biden stocks could ultimately benefit from this outburst, as it seems to tip the scales of the Georgia Senate runoffs – would determine whether President-elect Joe Biden has an acquiescent Congress to work with over at least the next two years.
"Further, the President's demand is arguably a net positive for Democrats' chances in the Georgia Senate races," Raymond James analysts say, "as Republicans will be forced on the defensive on support for the $2,000 checks and any delay on COVID relief."
(Stay on top of all the new stimulus bill developments – sign up for the FREE Kiplinger Today E-Newsletter!)
-
The Real Cost of Streaming Live Sports in 2025Streaming your favorite team keeps getting more expensive. Here’s the true cost of sports — and how to save.
-
It Could Soon Be Harder to Get a Refund on a Flight Gone WrongThe Department of Transportation's deregulation efforts are taking aim at your rights to compensation for delays, canceled flights, lost baggage and more.
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.
-
If You'd Put $1,000 Into UnitedHealth Group Stock 20 Years Ago, Here's What You'd Have TodayUNH stock was a massive market beater for ages — until it wasn't.
-
If You'd Put $1,000 Into Berkshire Hathaway Stock 20 Years Ago, Here's What You'd Have TodayBerkshire Hathaway is a long-time market beater, but the easy money in BRK.B has already been made.
-
If You'd Put $1,000 Into Procter & Gamble Stock 20 Years Ago, Here's What You'd Have TodayProcter & Gamble stock is a dependable dividend grower, but a disappointing long-term holding.
-
My Three-Day Rule for Investing: And If it Applies NowStock Market I've seen a lot in my career. Here's what I see now in the stock market.
-
Is It Time to Invest in Europe?Stock Market Europe is being shaken out of its lethargy, militarily and otherwise, by Donald Trump's changes in U.S. policy. Should investors start buying?
-
Why Is Warren Buffett Selling So Much Stock?Berkshire Hathaway is dumping equities, hoarding cash and making market participants nervous.
-
If You'd Put $1,000 Into Google Stock 20 Years Ago, Here's What You'd Have TodayGoogle parent Alphabet has been a market-beating machine for ages.
